WILLIAM D YOUNG
CIK 1217420 · Chairman and CEO · last filed 2026-07-01
WILLIAM D YOUNG is a Chairman and CEO who has filed 44 SEC Form 4 insider transactions across 7 companies since 2007. The most recent filing, for AUTL, was dated Jul 1, 2026. Across all open-market trades the lifetime net is −$11.2M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $18.7M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$18.69M
7
44
-$11.22M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| AUTL | Director | — | $2.07 | — | $0 | 1 | 2026-07-01 |
| PRAX | Director | 3,269 | $366.96 | $1.20M | $0 | 7 | 2026-06-12 |
| TBPH | Director | 78,010 | $16.91 | $1.32M | $0 | 8 | 2022-04-28 |
| VRTX | Director | 29,311 | $523.91 | $15.36M | -$10.94M | 8 | 2020-06-03 |
| BMRN | Director | 11,875 | $68.88 | $818.0K | $0 | 5 | 2015-06-18 |
| Innoviva, Inc. (THRX) Delisted | Director | 52,129 | $4.06 | $211.6K | -$388.0K | 10 | 2013-04-26 |
| Monogram Biosciences, Inc. (MGRM) Delisted | Chairman and CEO | 43,852 | $6.00 | $263.1K | $105.5K | 5 | 2009-01-22 |
Recent Filings
44 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-07-01 | AUTL | Grant (A) | — | $0 | EDGAR |
| 2026-06-12 | PRAX | Grant (A) | +1,371 | $0 | EDGAR |
| 2025-06-27 | PRAX | Grant (A) | — | $0 | EDGAR |
| 2024-06-06 | PRAX | Grant (A) | — | $0 | EDGAR |
| 2023-06-14 | PRAX | Grant (A) | — | $0 | EDGAR |
| 2022-05-27 | PRAX | Grant (A) | — | $0 | EDGAR |
| 2022-04-28 | TBPH | Grant (A) | +9,852 | $0 | EDGAR |
| 2021-07-07 | PRAX | Other (J) | +28,473 | $0 | EDGAR |
| 2021-06-09 | PRAX | Grant (A) | — | $0 | EDGAR |
| 2021-04-29 | TBPH | Grant (A) | +9,828 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.